Literature DB >> 21844077

Risk of constrictive pericarditis after acute pericarditis.

Massimo Imazio1, Antonio Brucato, Silvia Maestroni, Davide Cumetti, Riccardo Belli, Rita Trinchero, Yehuda Adler.   

Abstract

BACKGROUND: Constrictive pericarditis (CP) is considered a rare, dreaded possible complication of acute pericarditis. Nevertheless, there is a lack of prospective studies that have evaluated the specific risk according to different etiologies. The aim of this study is to evaluate the risk of CP after acute pericarditis in a prospective cohort study with long-term follow-up. METHODS AND
RESULTS: From January 2000 to December 2008, 500 consecutive cases with a first episode of acute pericarditis (age, 51±16 years; 270 men) were prospectively studied to evaluate the evolution toward CP. Etiologies were viral/idiopathic in 416 cases (83.2%), connective tissue disease/pericardial injury syndromes in 36 cases (7.2%), neoplastic pericarditis in 25 cases (5.0%), tuberculosis in 20 cases (4.0%), and purulent in 3 cases (0.6%). During a median follow-up of 72 months (range, 24 to 120 months), CP developed in 9 of 500 patients (1.8%): 2 of 416 patients with idiopathic/viral pericarditis (0.48%) versus 7 of 84 patients with a nonviral/nonidiopathic etiology (8.3%). The incidence rate of CP was 0.76 cases per 1000 person-years for idiopathic/viral pericarditis, 4.40 cases per 1000 person-years for connective tissue disease/pericardial injury syndrome, 6.33 cases per 1000 person-years for neoplastic pericarditis, 31.65 cases for 1000 person-years for tuberculous pericarditis, and 52.74 cases per 1000 person-years for purulent pericarditis.
CONCLUSIONS: CP is a relatively rare complication of viral or idiopathic acute pericarditis (<0.5%) but, in contrast, is relatively frequent for specific etiologies, especially bacterial.

Entities:  

Mesh:

Year:  2011        PMID: 21844077     DOI: 10.1161/CIRCULATIONAHA.111.018580

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

Review 1.  Constrictive pericarditis: old disease, new approaches.

Authors:  Terrence D Welch; Jae K Oh
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 2.  Recurrent Pericarditis: Modern Approach in 2016.

Authors:  Massimo Imazio; Yehuda Adler; Philippe Charron
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 3.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

Review 4.  Tuberculous pericarditis with and without HIV.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 5.  Effusive-constrictive pericarditis.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi; Jae K Oh
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

6.  Pharmacotherapy: Colchicine for recurrent pericarditis--what's new in CORP-2?

Authors:  Faisal F Syed; Bongani M Mayosi
Journal:  Nat Rev Cardiol       Date:  2014-05-27       Impact factor: 32.419

Review 7.  Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications.

Authors:  Kishendree Naicker; Mpiko Ntsekhe
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 8.  The Role of Epicardial Fat in Pericardial Diseases.

Authors:  George Lazaros; Alexios Antonopoulos; Charalambos Antoniades; Dimitris Tousoulis
Journal:  Curr Cardiol Rep       Date:  2018-04-19       Impact factor: 2.931

Review 9.  Recurrent pericarditis: new and emerging therapeutic options.

Authors:  Massimo Imazio; George Lazaros; Antonio Brucato; Fiorenzo Gaita
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

10.  Severe constrictive pericarditis after parvovirus B19 and human herpes virus 6 infection in a 9-year-old girl.

Authors:  David Backhoff; Michael Steinmetz; Wolfgang Ruschewski; Barbara Stastny; Reinhard Kandolf; Ulrich Krause
Journal:  Pediatr Cardiol       Date:  2013-07-18       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.